Metabolomics Market - Trends Forecast Till 2028

Metabolomics Market, Product (GC,UPLC, CE, Surface based Mass Analysis), Application (Biomarker Discovery, Drug Discovery, Functional Genomics), Indication (Cardiology, Oncology, Inborn Errors), End User (Academic Institute, CROs) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: January, 2021

Base Year Estimate: 2020

Report ID: D-PH-MM-66

Format:  

Number of Pages: 352

Domain: Pharmaceutical

Metabolomics Market – Trends Forecast Till 2028

The global Metabolomics market is anticipated to reach USD 2.1 billion in 2021 growing at a CAGR of 13.1% during the forecasting period, 2021-2028. 

Metabolomics is used widely in various disease research areas. Mass spectrometry is one of the highly applicable technologies in various basic disciplines, identification of endogenous substances in living organisms and, providing technical support for the discovery. Furthermore, this technology plays a vital role in disease treatment (such as bladder cancer, cardiovascular disease, breast cancer, kidney cancer, gastric cancer, natural metabolic errors, nutrition, and toxicological effects) animal and plant research, drug characterization and agricultural research, and nutrition

Increasing R&D expenditure for pharmaceutical and biotechnology, and increasing demand for personalized medicine are some of the factors that have supported long-term expansion for the metabolomics industry. 

Metabolomics Market – Trends Forecast Till 2028

The global metabolomics market is segmented into product, application, indication, end-user, and geography.

Product segment is segmented into GC, UPLC, CE, and Surface-based Mass Analysis

Indication segment is segmented into Cardiology, Oncology, and Inborn Errors 

End-User segment is segmented into Academic Institute and CROs

Application segment is segmented into Biomarker Discovery, Drug Discovery, and Functional Genomics

Geographically, the global metabolomics market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Asia-Pacific region has recorded the highest growth rate in the overall global market during the forecast period 2021-2028.

Key players in the global metabolomics market are Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, Danaher Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, GE Healthcare, Hitachi High-Technologies Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Scion Instruments, DANI Instruments S.p.A., GL Sciences, SRI Instruments, Kore Technology Ltd., and JASCO, Inc., among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2016, Agilent Technologies Inc. launched wide-ranging systems, software, and technologies designed to develop both the accuracy and speed of mass spectrometry

Available Customizations

In addition to the market data for the Metabolomics market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conferences like Jefferies conference)—to identify and collect information useful for this study of the Metabolomics market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global Metabolomics market. Through secondary research, the market is classified and segmented as per of industry trend, development, regional market. Product and technology development. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the Metabolomics market.

Primary Respondent breakdown is given below:

Metabolomics Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the Metabolomics market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the metabolomics market so as to understand the trends and the factors involved in changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 2.1 billion

Growth Rate

CAGR of 13.1% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year 

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product, Application, Indication, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, Danaher Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, GE Healthcare, Hitachi High-Technologies Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Scion Instruments, DANI Instruments S.p.A., GL Sciences, SRI Instruments, Kore Technology Ltd., and JASCO, Inc., among others

Available Customization 

In addition to the market data for the metabolomics market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.